Media stories about InfuSystem Holdings (NYSE:INFU) have been trending somewhat positive recently, according to Accern. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. InfuSystem Holdings earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned media stories about the medical instruments supplier an impact score of 46.2663016692521 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

InfuSystem Holdings (NYSE:INFU) traded down 3.53% during midday trading on Friday, hitting $2.05. 4,182 shares of the stock traded hands. The company has a 50-day moving average price of $1.92 and a 200-day moving average price of $1.88. InfuSystem Holdings has a 1-year low of $1.20 and a 1-year high of $2.80. The firm’s market cap is $46.65 million.

InfuSystem Holdings (NYSE:INFU) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported ($0.02) EPS for the quarter. InfuSystem Holdings had a negative net margin of 6.53% and a negative return on equity of 9.02%. The firm had revenue of $16.94 million during the quarter. Analysts predict that InfuSystem Holdings will post $0.24 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at

In related news, Director Meridian Ohc Partners, Lp bought 19,982 shares of the business’s stock in a transaction on Monday, September 11th. The shares were bought at an average cost of $2.00 per share, for a total transaction of $39,964.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Darrell B. Montgomery bought 25,000 shares of the business’s stock in a transaction on Monday, August 14th. The shares were bought at an average price of $1.88 per share, for a total transaction of $47,000.00. Following the completion of the acquisition, the director now owns 12,000 shares of the company’s stock, valued at $22,560. The disclosure for this purchase can be found here. Insiders purchased 191,029 shares of company stock worth $360,262 in the last 90 days.

InfuSystem Holdings Company Profile

InfuSystem Holdings, Inc is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada.

Insider Buying and Selling by Quarter for InfuSystem Holdings (NYSE:INFU)

Receive News & Ratings for InfuSystem Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem Holdings Inc and related companies with's FREE daily email newsletter.